Company / CapEx per Share
Arcadia Biosciences, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.00 / $1.82
FY2021-FY2025
Trend
+201.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +201% YoY in FY2025, a notable deviation from the 9-year average annual change of +456%.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -41.5%.
Declined from $0.12 to $0.01 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -81.4%
- 5-Year CAGR
- -41.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 201.3% year-over-year.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +201.3% |
| FY2024 | $0.00 | -96.7% |
| FY2023 | $0.12 | -93.6% |
| FY2022 | $1.82 | +945.9% |
| FY2021 | $0.17 | +1.6% |
| FY2020 | $0.17 | +226.3% |
| FY2019 | $0.05 | +41.4% |
| FY2018 | $0.04 | -64.4% |
| FY2017 | $0.10 | +2938.7% |
| FY2016 | $0.00 | -95.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026